If the goal is to enroll as many people as possible in a precision medicine program, the process has to be easy for patients, regardless of their condition, geographic location, or socioeconomic situation. That is the aim of the Multiple Myeloma Research...
GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing. This case-based discussion will...
We are experiencing unprecedented times, as the impact of COVID-19 has challenged our daily lives, our families, our communities, and our businesses. On behalf of My Gene Counsel, we hope you are staying well and staying home, and we especially want to thank all of...
2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
